Navigation Links
Conseco to Host Follow-Up Long-Term Care Conference Call
Date:9/27/2007

CARMEL, Ind., Sept. 27 /PRNewswire-FirstCall/ -- Conseco, Inc. (NYSE: CNO) will host a question and answer session on its long term care business at 3:00 p.m. Eastern Daylight Time today. During the company's long term care conference call earlier today, a technical problem at a service provider prevented callers from accessing the Q & A session that was to be part of that call.

To access the conference call, dial (888) 251-7470 and use the Conference ID 18906493.

The presentation from this morning's call is available through the investor section of Conseco's web site.

Conseco, Inc.'s insurance companies help protect working American families and seniors from financial adversity: Medicare supplement, long-term care, cancer, heart/stroke and accident policies protect people against major unplanned expenses; annuities and life insurance products help people plan for their financial futures. For more information, visit Conseco's web site at http://www.conseco.com.


'/>"/>
SOURCE Conseco, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Inexpensive ALL Follow-Up Test Developed By St. Jude Researchers
2. Due to Cost, Heart Attack Patients Often Avoid Follow-up Care and Medication
3. Breast Cancer Patients Follow-up Devalued
4. Experts Stress Need for Follow-up Evaluation of Children Who Fail Hearing Loss Screening
5. Pancreatitis: Minimially Invasive Procedure Offers Long-Term Pain Relief
6. Long-Term Survival can be Predicted by a Simple Lung Test
7. Small lumps in breast if not treated may cause long-term harm
8. Lung Therapy Found To Have Long-Term Side Effects
9. Long-Term Benefits Of Statins Questioned
10. Long-term use of calcium supplements to prevent colon cancer
11. Survivors of childhood cancer may have long-term health problems

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...er 20, 2009Emergency medical service (EMS) provide...0 cardiac arrests each year. Only 5 to 10 percent... Better quality cardiopulmonary resuscitation (CP...sociated with better patient outcome. The Resusci...inical research network to study prehospital treat...
(Date:11/20/2009)... buying 90-day supply, study finds , , F...month supply of prescription drugs is up to one-th...ing to a new study. , U.S. researchers analyzed... 2000 and 2005, and found that patients who bought...y saved an average 29 percent in out-of-pocket cos...
(Date:11/20/2009)...time OB/GYN warns against the new breast cancer re...rvices Task Force. These guidelines may be cost-ef.... When is it wrong to be safe than sorry? , ...ces Task Force recommendations, published in the c...as set off a firestorm in the medical community. M...
(Date:11/20/2009)...alif., Nov. 20 Omnicell,...m solutions to acute healthcare facilities, announ...nual Piper Jaffray Healthcare Conference at the N...ell Speakers: Randall A. Lipps, founder, chairman... & CFO ,, Date: Tuesday, December 1, 2009...
(Date:11/20/2009)... Today, iconic denim brand DKNY ...launch of a capsule gift giving collection offered...ason. This collection is inspired by and designed...anks and Giving® Program, a holiday fundrais...rs to "give thanks for the healthy kids in your li...
Breaking Medicine News(10 mins):Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 3Health News:Three-Month Supply Lowers Drug Costs 2Health News:New Breast Cancer Recommendation May Cost Lives While Saving Money 2Health News:New Breast Cancer Recommendation May Cost Lives While Saving Money 3Health News:Omnicell to Present at Piper Jaffray Healthcare Conference 2Health News:DKNY JEANS Launches Exclusive Collection With HSN for St. Jude Children's Research Hospital's Thanks and Giving(R) Campaign 2Health News:DKNY JEANS Launches Exclusive Collection With HSN for St. Jude Children's Research Hospital's Thanks and Giving(R) Campaign 3
...oviders play a key role in the likelihood their pa...dings suggest that interventions targeting both th...orectal cancer screening rates, and in particular ... 15, 2008 issue of CANCER, a peer-reviewed journal...
...ight help to pour that diet soda down the drain. R...pread use of no-calorie sweeteners may actually ma...d body weight. The findings appear in the February...e Behavior Research Center reported that relative ...
... Fred Hutchinson Cancer Research Center has identi...ent ovarian tumors become resistant to treatment w...s such as cisplatin and carboplatin. They describe...utations in the BRCA2 gene, they also may help exp...
...y burden , , SUNDAY, Feb. 10 (HealthDay Ne..., and doctors have long been familiar with this cu...wife dies, there,s a greater likelihood that the s...with the hospitalization of a spouse. , New find...
...wing,a voluntary recall by Chattem, Inc., announce...m sale. Chattem is recalling these products based ...ree burns as well as skin,irritation resulting fro...ll:, 1. Icy Hot Heat Therapy Air Activated Heat-...
... volume on personal music players , , SATU...t -- or about 5 million -- American youngsters hav...irely preventable, says the American Academy of Au...be prevented simply by turning down the volume of ...
Other Medicine News:Health News:Provider influence and patient barriers affect use of colorectal cancer screening 2Health News:Artificial sweeteners linked to weight gain 2Health News:Artificial sweeteners linked to weight gain 3Health News:Study reveals why certain ovarian cancers develop resistance to platinum-based chemotherapy 2Health News:Spouse's Sickness Bodes Ill for Partner's Health 2Health News:Spouse's Sickness Bodes Ill for Partner's Health 3Health News:Giant Food Alerts Customers to Voluntary Recall of Chattem Icy Hot Heat Therapy Products 2Health News:Campaign Targets Noise-Induced Hearing Loss in Kids 2
(Date:11/20/2009)...MEMPHIS, Tenn., Nov. 20 /PRNewswire-FirstCall/ -...Division is pleased to announce the signing of a t...tes Department of Defense that may lead to the cre...volutionize the treatment of the limbs of soldiers..., the Defense Advanced Research Projects Agency (D...
(Date:11/19/2009)..., ARDEE, Ireland, Nov. 19 Warner C...ricing of its previously announced secondary offer...e to the public of $22.25 per share. The selling ...pital Partners, DLJ Merchant Banking, J.P. Morgan ...ee Partners, L.P., certain other institutional inv...
(Date:11/19/2009)... LYON, France, Nov. 19 In response...g dangerous and illegal medicines, Operation Pange...NTERPOL and the World Health Organization,s Intern...orce (IMPACT) to highlight the dangers of buying m...tive resulted in a series of arrests and the seizu...
Breaking Medicine Technology:Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 3Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 4Warner Chilcott Prices Secondary Equity Offering 2Warner Chilcott Prices Secondary Equity Offering 3Warner Chilcott Prices Secondary Equity Offering 4International Operation Combats Online Supply of Counterfeit and Illegal Medicines 2Scientists link genetic glitches to common childhood cancer 9603 1Scientists link genetic glitches to common childhood cancer 9603 2Water quality improves after lawn fertilizer ban study shows 9599 1Water quality improves after lawn fertilizer ban study shows 9599 2American Home Companions Makes Inc 5000 List Again 54656 1American Home Companions Makes Inc 5000 List Again 54656 2
... Disease is Leading Cause of Death for Infants, W...usiness unit of Genzyme Corporation (Nasdaq: GENZ...laboratory specializing in reproductive,testing to...c testing for,spinal muscular atrophy (SMA), the m...is test will enable couples who are planning a pre...
... MP-470,s role in overcoming erlotinib resistance,... SUPG ), a pharmaceutical company dedicated to th...on of therapies for solid tumors and,hematological... of,presentations at the 2008 AACR Annual Meeting ...east cancer cells to erlotinib (Abstract No.,671)....
Other Medicine Technology:Genzyme Genetics Announces Launch of Carrier Testing and Prenatal Diagnosis for Spinal Muscular Atrophy 2Genzyme Genetics Announces Launch of Carrier Testing and Prenatal Diagnosis for Spinal Muscular Atrophy 3Genzyme Genetics Announces Launch of Carrier Testing and Prenatal Diagnosis for Spinal Muscular Atrophy 4SuperGen's MP-470 Sensitizes Prostate and Breast Cancer Cells to Erlotinib 2
Operative Eyecup Laparoscope w ith reverse light post
USA Series™ 5 mm Laparoscopes
Pediatric Laparoscopes
Unheated Anaerobic Chamber with Automatic Airlock - Model C
Medicine Products: